Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Issuer Symbol
-
INAB on Nasdaq
There are no Buy or Sell transactions made by Leslie W. Kreis since 05 Jan 2025
Holdings reported by Leslie W. Kreis for IN8BIO, INC.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3,727,597 |
$559,139 |
$0.1500 |
02 May 2025 |
By Bios Fund III QP, LP |
|
|
| Common Stock |
1,876,624 |
$281,493 |
$0.1500 |
02 May 2025 |
By Bios Fund II QP, LP |
|
|
| Common Stock |
997,433 |
$149,614 |
$0.1500 |
02 May 2025 |
By BIOS Incysus Co-Invest I, LP |
|
|
| Common Stock |
601,980 |
$90,297 |
$0.1500 |
02 May 2025 |
By Bios Fund III, NT, LP |
|
|
| Common Stock |
574,432 |
$86,164 |
$0.1500 |
02 May 2025 |
By Bios Fund II, LP |
|
|
| Common Stock |
570,724 |
$85,608 |
$0.1500 |
02 May 2025 |
By Bios Fund III, LP |
|
|
| Common Stock |
251,211 |
$37,681 |
$0.1500 |
02 May 2025 |
By Bios Fund II NT, LP |
|
|
| Pre-Funded Warrants |
2,431,763 |
|
|
02 May 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
|
| Series C Warrant |
709,040 |
|
|
02 May 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
|
| Stock Option |
85,000 |
|
|
02 May 2025 |
Indirect |
Common Stock |
85,000 |
| Series A Warrant |
0 |
|
|
02 May 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
|
| Series B Warrant |
0 |
|
|
02 May 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
574,241 |
Transactions reported by Leslie W. Kreis for IN8BIO, INC.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.